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Kidney Res Clin Pract 33 (2014) A1–A7A462.22%, po0.0001) and non-calcium phosphorous binders (0%,
0%, 0%, 0%, 13.33%, po0.0001) were prescribed signiﬁcantly
more often in advanced CKD. Calcium x phosphorus was sig-
niﬁcantly increased in advanced CKD (11.59%, 17.39%, 28.26%,
21.01%, 21.74%, p¼0.002).
Conclusion: As CKD progressed, hyperphosphatemia, hyperpar-
athyroidism and 1,25D3 deﬁciency increased, serum FGF-23 level
increased and urinary phosphorus excretion decreased in chil-
dren with CKD stage I to V predialysis.
http://dx.doi.org/10.1016/j.krcp.2014.05.021
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Background: Hypokalemia has been suggested to be a risk
factor in peritoneal dialysis (PD). Recently in US, a large perito-
neal dialysis cohort study showed potassium abnormalities
contribute disproportionately to the high death risk in PD
patients. This issue was reviewed in Korean ESRD cohort com-
paring to hemodialysis (HD).
Patients and methods: A nationwide prospective observational
cohort study (CRC-ESRD) was performed between August 2008 and
October 2013. Among them, patients had been selected who checked
serum potassium level at least twice within 18 months. Overall
mortality rate was evaluated as outcome. Patients were divided into
following four groups based on time-averaged potassium level:
Ko3.5, 3.5rKo4.5, 4.5rKo5.5, Z5.5 mg/dL. They were ana-
lyzed to determine association of serum potassium with mortality
using Cox proportional hazard model.
Results: Follow-up data were available for 1,686 patients (HD
62.3%, PD 37.7%). The mean age was 58.2713.9 years, and the
ratio of men to women was 57% to 43%. Overall duration of dialysis
was 1.973.9 years. PD patients signiﬁcantly had lower serum
potassium level comparing to HD patients (po0.001). Serum
potassium was o3.5 mg/dL in 10.7% of PD patients, whereas 2.2%
in HD patients. During the mean 2.2 year follow up period, 142
patients died of mainly cardiac arrest and infection. Univariate
analysis indicated that older age, history of congestive heart failure
or diabetes could be the risk factor for mortality. Multivariate
analysis proved PD patients with o3.5 mg/dL of time-averaged
serum potassium to have all-cause mortality with adjusted hazard
ratio of 2.5 (95% CI, 1.33-4.41) (p¼0.004), whereas, HD patients was
not. Among adjusted variables, PD patients who had diabetes or
congestive heart failure tended to have higher risk of death withadjusted hazard ratio 1.7 (95% CI, 0.99-2.76) and 2.3 (95% CI 1.24-
4.19) respectively.
Conclusion: PD patients with hypokalemia (o3.5 mg/dL) have
higher mortality risk. This study conﬁrmed the previous cohort
study in different ethnic group. Therefore, regardless of ethnicity,
this result could be accepted.
http://dx.doi.org/10.1016/j.krcp.2014.05.022
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Background: The role of HBV and HCV infections in survival among
dialysis patients remains incompletely understood. This study inves-
tigated the prevalence of hepatitis B or C infection and its impact on
survival in Korean patients on maintenance dialysis.
Methods: The study included 3,321 maintenance dialysis patients
who underwent hepatitis B antigen (HBsAg) and HCV antibody (Ab)
testing from amulticenter prospective cohort study in Korea. HBsAg-
positive and HCV Ab-positive patients were matched to hepatitis
virus-negative patients using propensity score by a ratio of one to
two. We compared the survival of HBsAg and HCV Ab-positive
patients to that of hepatitis virus-negative patients.
Results: A total of 221 (6.7%) HBsAg-positive and 108 (3.7%) HCV
Ab-positive patients were enrolled and followed up for mean
23.5713.3 months. Patients with dialysis vintage of Z10 years
showed a signiﬁcantly higher prevalence of HBV and HCV than
patients with dialysis vintage of o1 year (HBV 10.2% vs. 5.6%,
p¼0.011 and HCV 7.5% vs. 3.3%, p¼0.003, respectively). After
propensity score matching, the cumulative survival was not
different between HBsAg-positive and hepatitis virus-negative
patients (p¼0.370). However, HCV Ab-positive patients showed
